Research Library

The top resource for free research, white papers, reports, case studies, magazines, and eBooks.

Share Your Content with Us
on TradePub.com for readers like you. LEARN MORE
COVID-19 Vaccines and the Pandemic's Third Year
Request Your Free Special Report Now:

"COVID-19 Vaccines and the Pandemic's Third Year"

The U.S. and Europe have shifted their focus toward booster doses, which have been proven critical in protection against new strains. Learn the latest developments in this Trendline.

The world is still grappling with how to stay ahead of a mutating coronavirus. The vaccine focus has now shifted to sustaining longer-term efforts, and developers like Pfizer and Moderna have successfully updated their vaccines to better match circulating omicron variants.

Included in this Trendline:

  • Pfizer, BioNTech data support new Covid booster’s advantage over original vaccine
  • Novavax details trial results for omicron-targeting booster shots
  • Moderna cuts sales forecasts for its COVID-19 vaccine


Offered Free by: BioPharma Dive and PHC Corporation of North America
See All Resources from: BioPharma Dive and PHC Corporation of North America

Recommended for Professionals Like You:

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.